1.
Ravasio R, Marcellusi A, De Nicola L. Economic impact of dapagliflozin in the management of chronic kidney disease in Italy: results from a micro-simulation model. Grhta [Internet]. 2024 Dec. 2 [cited 2024 Dec. 5];11(1):231-8. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/3309